糖尿病肾脏病防治研究进展——第41届美国肾脏病学会年会相关内容介绍
被引量：1
摘要
2008年11月4～9日在美国费城举行了美国肾脏病学会第41届年会，会议主题之一是糖尿病肾脏病防治。现将有关内容作一介绍。
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2009年第6期406-408,共3页
Chinese Journal of Diabetes
参考文献22
-
1KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.Am J Kidney Dis,2007,49(2 Suppl 2):S12-154.
-
2The SEARCH for Diabetes in Youth Study Group.Incidence of diabetes in youth in the United States:the SEARCH for Diabetes in Youth Study.JAMA,2007,297:2716-2724.
-
3Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of intensive glucose lowering in type 2 diabetes,New Engl J Med,2008,358:2545-2559.
-
4ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.New Engl J Med,2008,358:2560-2572.
-
5Hoogwerf BJ,Doshi KB,Diab D.Pramlintide,the synthetic analogue of amylin:physiology,pathophysiology,and effects on glycemic control,body weight,and selected biomarkers of vascular risk.Vasc Health Risk Manag,2008,4:355-362.
-
6Cvetkovic RS,Plosker GL.Exenatide:a review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea).Drugs,2007,67:935-954.
-
7Kim D,MacConell L,Zhuang D,et al.Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.Diabetes Care,2007,30:1487-1493.
-
8Richter B,Bandeira-Echtler E,Bergerhoff K,et al.Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.Vasc Health Risk Manag,2008,4:753-768.
-
9Ban CR,Twigg SM.Fibrosis in diabetes complications:pathogenic mechanisms and circulating and urinary markers.Vasc Health Risk Manag,2008,4:575-596.
-
10Gohda T,Tanimoto M,Moon JY,et al.Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.Diabetes Res Clin Pract,2008,81:196-201.
同被引文献14
-
1常洁,姜宗培,余学清.氧化应激及其在糖尿病肾病中的作用[J].国际内科学杂志,2007,34(2):105-108. 被引量：25
-
2Morrow JD,Roberts LJ.Mass spectrometry of prostanoids:F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism.Methods Enzymol,1994,233:163-174.
-
3Zwart LL,Meerman JH,Commandeur JN,et al.Biomarkers of free radical damage:applications in experimental animals and in humans.Free Radic Biol Med,1999,26(1-2):202-226.
-
4Pratico D,Lawson JA,Rokach J,et al.The isoprostanes in biology and medicine.Trends Endocrinol Metab,2001,12(6):243-247.
-
5Pratico D.F2-isoprostanes:sensitive and specific non-invasive indices of lipid peroxidation in vivo.Atherosclerosis,1999,147(1):1-10.
-
6Helmersson J,Vessby B,Larsson A,et al.Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.Circulation,2004,109(14):1729-1734.
-
7Gopaul NK,Manraj MD,Hebe A,et al.Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism.Diabetologia,2001,44(6):706-712.
-
8Davì G,Ciabattoni G,Consoli A,et al.In vivo formation of 8-iso-prostaglandin F2а and platelet activation in diabetes mellitus:effects of improved metabolic control and vitamin E supplementation.Circulation,1999,99(2):224-229.
-
9Gopaul NK,Halliwell B,Anggard EE.Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet.Free Radic Res,2000,33(2):115-127.
-
10Takahashi K,Nammour TM,Fukunaga M,et al.Glomerular actions of a free radical-generated novel prostaglandin,8-epi-prostaglandinF2a,in the rat.J Clin Invest,1992,90(1):136-141.
二级引证文献3
-
1鞠海兵,徐昕明,舒子正,王光琳,李丽风,宋洁,孙晓娟,于菁.叶酸对2型糖尿病患者8-异前列腺素F2α和6-酮前列腺素F1α的影响[J].中国医药,2012,7(10):1236-1238. 被引量：1
-
2郑海建,谢燕,王翎.血浆8-异前列腺素F2a与糖尿病血管内皮损伤的关系[J].中国老年学杂志,2012,32(22):4904-4906. 被引量：4
-
3陈波.精神分裂症患者血浆8-异前列腺素F2α水平变化与机体氧化应激的关系[J].医学临床研究,2017,34(3):561-563. 被引量：3
-
1姜庆.慢性前列腺炎的药物治疗进展[J].局解手术学杂志,2006,15(6). 被引量：1
-
2赵荣华.肛肠外科腹腔镜技术应用研究进展——2005年美国肛肠外科医师学会腹腔镜专题综述[J].上海医学,2005,28(10):820-821.
-
3第18届美国腹腔镜外科学会年会(SLS)[J].中国现代医生,2009,47(11):98-98.
-
4支修益,李辉,万峰.第86届全美胸外科协会年会内容精选[J].中华医学信息导报,2006,21(13):6-7.
-
5杨占清,刘运喜,谢明星,孟祥瑞,掌友湖.山东地区人畜（禽）军团菌自然感染血清流行病学调查[J].前卫医药杂志,1993,10(3):133-134.
-
6谌贻璞.糖尿病肾脏病诊断与防治中的几个问题[J].临床肾脏病杂志,2009(4):148-150.
-
7彭涛,王林.炎症和免疫系统疾病峰会[J].国外医学（药学分册）,2005,32(5):353-354. 被引量：1
-
8钱程,薛庆生,于布为,张富军.Toll样受体4在神经病理性疼痛发病机制中的作用[J].国际麻醉学与复苏杂志,2015,36(10):929-932. 被引量：2
-
9美研究人员发现杀伤性T细胞新受体[J].中国艾滋病性病,2009,15(2):169-169.
-
10Plk1的小分子抑制剂表现出了强烈的抗癌活性[J].基础医学与临床,2005,25(4):357-357.
